SCHEMBL6923951

SCHEMBL6923951

COc1ccc2ccn(-c3ccccc3[N+](=O)[O-])c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.47
PTK2 Q05397 1/20 0.47
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 4/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 2/20 0.45
ROCK1 Q13464 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
POLB P06746 1/20 0.42
FABP4 P15090 1/20 0.42
TTR P02766 1/20 0.41
HTT P42858 1/20 0.41
AKR1C3 P42330 2/20 0.41
AKR1C2 P52895 2/20 0.41
AKR1B10 O60218 1/20 0.41
AKR1B1 P15121 1/20 0.41
AKR1C4 P17516 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30411927 0.79 ALDH1A1 (0.44) PTK2KMT2AALDH1A1SMN1; SMN2HTT
SCHEMBL5661381 0.79 ALDH1A1 (0.44) PTK2KMT2AALDH1A1SMN1; SMN2HTT
SCHEMBL7513251 0.78 PTK2 (0.44) PTK2KMT2AMEN1MAPTALDH1A1
SCHEMBL28894224 0.77 MAOB (0.49) MAOBKMT2AMEN1MAPTALDH1A1
SCHEMBL17067714 0.75 HSP90AA1 (0.46) MAOBPTK2KMT2AMEN1MAPT
SCHEMBL5432686 0.74 LMNA (0.44) MAPTALDH1A1MAPK1ROCK1SMN1; SMN2
SCHEMBL6298933 0.74 KMT2A (0.51) PTK2KMT2AMEN1MAPTALDH1A1
SCHEMBL6298250 0.72 MAPK1 (0.46) PTK2KMT2AMEN1MAPTALDH1A1
SCHEMBL6363237 0.71 CYP19A1 (0.54) KMT2AMEN1MAPTALDH1A1MAPK1
SCHEMBL29126953 0.71 ALDH1A1 (0.52) MAPTALDH1A1MAPK1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004099139-A1 INDOLE-CONTAINING COMPOUNDS WITH ANTI-TUBULIN AND VASCULAR TARGETING ACTIVITY BAYLOR UNIVERSITY (US) 2004-11-18 WO disclosed